XBIT — XBiotech Inc
NASDAQ · Healthcare · Biotechnology
$2.20
-$0.02 (-0.90%)
XBiotech Inc (XBIT) is a biotechnology company listed on NASDAQ. It is led by John Simard, based in 5217 Winnebago Lane, Austin, TX, United States, 78744, with about 92 employees. XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Net income was -$6.0M. XBIT currently screens at market cap $83.8M.
Use this XBIT page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the XBIT quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the XBIT SEC filings page. Lician reads the product cache first so this HTML stays unique to XBiotech Inc even when a live quote feed is slow.
About XBiotech Inc
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
XBIT Key Statistics
Market Cap
$83.84M
Volume
52,121
Previous Close
$2.31
Day Range
$2.23 – $2.32
EPS
-$1.26
Revenue
$0.00
Net Income
-$38.53M
Gross Profit
$0.00
Free Cash Flow
$0.00
Employees
92
XBIT Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 |
| Net Income | -$38.53M | -$4.63M | -$3.20M |
| EPS (Diluted) | -$1.26 | -$0.81 | -$1.08 |
Total Assets
$199.09M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$172.68M
Operating Cash Flow
-$30.96M
Free Cash Flow
$0.00
XBiotech Inc Company Information
- Founder, President, CEO & Chairman
- John Simard
- Headquarters
- 5217 Winnebago Lane, Austin, TX, United States, 78744
- Website
- www.xbiotech.com
- Phone
- 512 386 2900
- IPO / Founded
- 2015-04-15
- Sector
- Healthcare
- Industry
- Biotechnology